Back to User profile » Dr Itaru Miura
Papers published by Dr Itaru Miura:
Duration Mismatch Negativity in Adults With Autism Spectrum Disorder Versus Healthy Controls
Sato A, Itagaki S, Ohnishi T, Osakabe Y, Hoshino H, Kanno K, Suzutani K, Wada T, Miura I, Yabe H
Neuropsychiatric Disease and Treatment 2025, 21:503-510
Published Date: 5 March 2025
Effect of Lurasidone on Life Engagement in Schizophrenia: Post-Hoc Analysis of the JEWEL Study
Maruyama H, Sano F, Sakaguchi R, Okamoto K, Miura I
Neuropsychiatric Disease and Treatment 2024, 20:1453-1463
Published Date: 24 July 2024
Lurasidone for the Treatment of Schizophrenia: Design, Development, and Place in Therapy
Miura I, Horikoshi S, Ichinose M, Suzuki Y, Watanabe K
Drug Design, Development and Therapy 2023, 17:3023-3031
Published Date: 28 September 2023
Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study
Miura I, Watabe K, Sakaguchi R, Okamoto K, Maruyama H
Neuropsychiatric Disease and Treatment 2022, 18:2627-2637
Published Date: 9 November 2022
Effect of Switching to Brexpiprazole on Plasma Homovanillic Acid Levels and Antipsychotic-Related Side Effects in Patients with Schizophrenia or Schizoaffective Disorder
Ichinose M, Miura I, Horikoshi S, Yamamoto S, Kanno-Nozaki K, Watanabe K, Yabe H
Neuropsychiatric Disease and Treatment 2021, 17:1047-1053
Published Date: 13 April 2021
Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report
Ito M, Kunii Y, Horikoshi S, Miura I, Itagaki S, Shiga T, Yabe H
International Medical Case Reports Journal 2019, 12:185-188
Published Date: 21 June 2019
COMT Val 108/158 Met polymorphism and treatment response to aripiprazole in patients with acute schizophrenia
Kaneko H, Miura I, Kanno-Nozaki K, Horikoshi S, Hino M, Yabe H
Neuropsychiatric Disease and Treatment 2018, 14:1657-1663
Published Date: 22 June 2018
The efficacy of antipsychotics for prolonged delirium with renal dysfunction
Asano S, Kunii Y, Hoshino H, Osakabe Y, Shiga T, Itagaki S, Miura I, Yabe H
Neuropsychiatric Disease and Treatment 2017, 13:2823-2828
Published Date: 16 November 2017
Hashimoto encephalopathy with high plasma monoamine metabolite levels: a case report
Horikoshi S, Miura I, Kunii Y, Asano S, Kanno-Nozaki K, Mashiko H, Yabe H
Neuropsychiatric Disease and Treatment 2017, 13:1043-1045
Published Date: 7 April 2017
Near-infrared spectroscopy and plasma homovanillic acid levels in bipolar disorder: a case report
Miura I, Kono S, Oshima S, Kanno-Nozaki K, Mashiko H, Niwa SI, Yabe H
Neuropsychiatric Disease and Treatment 2014, 10:507-511
Published Date: 25 March 2014